Linezolid Injection, Solution
Product Images NDC 66298-7131

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 66298-7131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hp Halden Pharma As, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag (Bag)

Bag (Bag)
NDC 63323-713-13 is an injection of Linezolid, with a strength of 600 mg in 300 mL (2 mg/mL). It is meant for intravenous infusion only, and should be used immediately after being removed from the overwrap. Each mL contains linezolid, dextrose, sodium citrate, citric acid, and water for injection, with a pH adjusted to 4.8. The solution is single-use, and any unused portion should be discarded. The usual adult dosage should be referred to, and no supplementary medication should be added. The container should be checked for leaks, and any leaks found, should be discarded. Linezolid solution may exhibit a yellow color that intensifies over time, but it does not affect its potency. It is stored at 20° to 25°C (68° to 77°F) and is sensitive to light. The container closure does not contain natural rubber latex and is Non-PVC, Non-DEHP, and Sterile. The manufacturer is Fresenius Kabi USA, LLC, and it is made in Norway with a manufacturing number of 13-133.*
FDA Label Image

Logo (Fk Address)

FDA Label Image

Figure 1 (Linezolid Fig1)

FDA Label Image

Linezolid Structure (Linezolid Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.